US EditionPublished • loading... • Updated
Making custom CRISPR therapies could be harder than initially thought
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Making custom CRISPR therapies could be harder than initially thought
Last year's successful treatment of an infant known as Baby KJ encouraged scientists to try again. But now, five weeks after the FDA outlined its plans to make such individualized genetic medicines more accessible, researchers are realizing how difficult it will be to meet those new requirements.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
